|
Market Cap (24-Jun) $19,510,578 (1,113th) |
Close (30-Jun) $0.049 |
Volume (30-Jun) 1,094,468 |
Shortsold (12-Jul) 1 (0.00%) (672nd) |
|
52w High $0.000 |
52w Low $0.000 |
P/E 20.45 |
EPS -0.02 |
PXS released this announcement to the ASX on 4 June 2021, 10:14. The announcement is not marked as price sensitive, and is 32 page(s) in length and 2.39MB in size.
You can view all announcements from PXS and see how they appear on a price chart on the announcements page.
At the date of this announcement, PXS was 0.041% short sold according to ASIC data. It was ranked the 498th most shorted stock on the ASX. It remains ranked 672nd as of the latest reported data (12 July 2023).
| Other Recent Announcements from PXS | |
|---|---|
| Investor presentation | 24 May 2023, 8:21 |
| PXS Announces Encouraging Results from Phase 1c Scar Study | 23 May 2023, 16:32 |
| Trading Halt | 22 May 2023, 8:56 |
| Investor Presentation - 4 June 2021 | 4 June 2021, 10:14 |
| Pharmaxis Investor Briefing | 31 May 2021, 11:06 |
| Change of Director's Interest Notice | 4 May 2021, 12:20 |
| Promising New Drug to Tackle Brain Cancer | 3 May 2021, 8:08 |
You must be logged in to post a reply.
Pharmaxis Ltd 